Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT07237750 Sponsor: Liu Yan Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT07237750
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are Asian and between 18 and 65 years old.
  • Your body weight falls within a specific range based on your height, with a BMI between 24.0 and 37.4 (using Chinese health standards).
  • You have already tried to lose weight through diet or lifestyle changes for at least 2 months without enough success.
  • You are willing to attend follow-up appointments as required by the trial.
  • You are willing to sign a consent form agreeing to take part.

Who may not be able to join:

  • You have had previous surgery on your stomach or digestive system that caused ongoing health problems.
  • You currently have or have had significant digestive conditions such as severe acid damage to the esophagus, Crohn's disease, stomach ulcers, or any growths or tumors in the digestive tract.
  • You have any condition that puts you at higher risk of bleeding in the upper part of your digestive system.
  • You have a hiatal hernia larger than 2 cm, severe acid reflux, or acid reflux that needs two or more medications to control.
  • You have a narrowing, pouch, or other structural problem in your throat or esophagus that could make it difficult to pass a medical camera (confirm with trial site).
  • You have achalasia or another serious condition affecting how your esophagus moves food.
  • You have a serious blood-clotting disorder.
  • You have diabetes that requires insulin injections.
  • You have ongoing or long-term abdominal pain.
  • You have a condition affecting how your stomach moves or empties food, such as gastroparesis.
  • You have significant liver disease or cirrhosis.
  • You have a severe or poorly controlled mental health condition.
  • You have problems with alcohol or drug dependence.
  • You are not willing to follow a diet and behavior change program supervised by a doctor, or you are unwilling to attend regular follow-up visits.
  • You regularly take anti-inflammatory painkillers (such as ibuprofen), blood thinners, or other medications known to irritate the stomach.
  • You are unwilling or unable to take a specific type of acid-reducing medication (called a proton pump inhibitor) as directed during the trial.
  • You are known to be allergic or sensitive to any part or material of the device used in this trial.
  • You are currently pregnant or breastfeeding.
  • You have serious heart or lung disease, or another serious illness affecting your whole body.
  • You have tested positive for a stomach infection called Helicobacter pylori (H. pylori).
  • You take certain time-sensitive medications — such as anti-seizure or heart rhythm drugs — that could be affected by changes in how quickly your stomach empties (confirm with trial site).
  • You are currently taking steroid medications, drugs that suppress your immune system, or strong opioid painkillers.
  • You have used any weight-loss medication in the past 3 months, or are currently using one.
  • You have previously had any device placed inside your stomach for weight loss.
  • You have taken part in another clinical trial that may affect your weight within the past 6 months.
  • You have heart failure with symptoms, a significant irregular heartbeat, or unstable heart disease.
  • You have a clinically significant breathing or lung condition.
  • You have an autoimmune condition affecting your connective tissues (such as lupus or rheumatoid arthritis).
  • Your life expectancy is less than one year, or you have severe kidney, liver, lung, or other serious medical illness.
  • Your obesity is caused by a known genetic condition or hormone-related condition, such as an underactive thyroid or Prader-Willi syndrome.
  • You have an eating disorder such as bulimia, binge eating disorder, or compulsive eating.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8601066947300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Liu Yan
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percent Total Body Weight Loss (%TBWL); Clinical Responder Rate (CRR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov